The U.S. asthma drugs market size is calculated at USD 9.25 billion in 2025 and is forecasted to reach around USD 14.36 billion by 2034, accelerating at a CAGR of 5.03% from 2025 to 2034. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: U.S. Asthma Drugs Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. U.S. Asthma Drugs Market Revenue and Volume, by Medication
8.1.1. Quick Relief Medications
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Long-term Control Medications
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Others
8.1.3.1. Market Revenue and Volume Forecast
9.1. U.S. Asthma Drugs Market Revenue and Volume, by Mode of Administration
9.1.1. Tablets and Capsules
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Liquids
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Inhalers
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Injections
9.1.4.1. Market Revenue and Volume Forecast
9.1.5. Sprays and Powders
9.1.5.1. Market Revenue and Volume Forecast
10.1. U.S. Asthma Drugs Market Revenue and Volume, by Source
10.1.1. Environmental
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Generic
10.1.2.1. Market Revenue and Volume Forecast
11.1. U.S. Asthma Drugs Market Revenue and Volume, by Organization Type
11.1.1. Public
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Private
11.1.2.1. Market Revenue and Volume Forecast
12.1. U.S. Asthma Drugs Market Revenue and Volume, by Application
12.1.1. Pediatric
12.1.1.1. Market Revenue and Volume Forecast
12.1.2. Adults
12.1.2.1. Market Revenue and Volume Forecast
12.1.3. Adolescent
12.1.3.1. Market Revenue and Volume Forecast
13.1. U.S.
13.1.1. Market Revenue and Volume Forecast, by Medication
13.1.2. Market Revenue and Volume Forecast, by Mode of Administration
13.1.3. Market Revenue and Volume Forecast, by Source
13.1.4. Market Revenue and Volume Forecast, by Organization Type
13.1.5. Market Revenue and Volume Forecast, by Application
14.1. Abbott
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Abbott
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Abbott
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Abbott
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Abbott
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Abbott
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Abbott
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Abbott
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Abbott
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Abbott
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client